To enhance the quality of the working environment for employees and gradually modernize infrastructure for management purposes, Cuu Long Pharmaceutical Joint Stock Company (DCL) has officially launched a project to construct a new executive building at its headquarters.
After many years of use, the current executive building has shown limitations in functionality and workspace, no longer meeting the needs of the company’s expanding operations. “Given this reality, DCL’s leadership has agreed on the plan to upgrade and construct a new executive building with a modern scale, full amenities, aesthetic appeal, functional design, and alignment with the company’s long-term development strategy,” shared Mr. Luong Ngoc Luong, Head of Construction Investment Management at F.I.T Group.
According to the plan, the new executive building will have three floors with a total floor area of over 1,200 m²: the ground floor covering 429 m², and both the first and second floors covering 402 m² each. The building’s design emphasizes open, airy workspaces that maximize natural light while integrating various supporting facilities such as multi-purpose meeting rooms, reception areas, and collaborative workspaces.
Front perspective of DCL’s new executive building
This project represents not only an infrastructure upgrade but also DCL’s long-term commitment to investing in people – the central element of the company’s sustainable development strategy. Creating a modern, professional, and convenient working environment will contribute to improved productivity, foster creativity, and strengthen employee engagement across the organization.
The new executive building is expected to be completed and operational by early 2026.
A representative from DCL’s leadership stated: “We recognize that people are the core of every success. Upgrading and constructing a new executive building is not only about improving infrastructure but also a strategic investment in the future, demonstrating our commitment to support and provide the best conditions for our employees to grow and contribute.”
In an ever-evolving pharmaceutical industry that demands high management capacity and innovation, building the new executive building is a practical step for DCL to strengthen its internal capabilities, further asserting its position in the industry and better meeting the growing needs of the market and customers.
Investing systematically in facilities also clearly reflects DCL’s long-term vision and efforts to create an ideal working environment where each individual is inspired, fully supported, and empowered to contribute positively to the company’s overall development.
